EBCAM:加味滋肾通管汤配合针刺治疗宫颈癌术后尿潴留的疗效观察

2021-12-28 Vivi MedSci原创

探讨加味滋肾通管汤配合针刺治疗宫颈癌术后尿潴留的疗效观察及对不良反应发生率的影响

背景:宫颈癌术后膀胱收缩恢复时间长,尿潴留的发生率很高。目前临床上多采用留置导尿管作为常规治疗方法,但由于长期滞留易引起感染,治疗效果较差。在导尿等常规治疗的基础上加用中医药治疗效果显著,滋肾通管汤具有活血化瘀、补肾、利尿等作用,可改善术后排尿功能,加速患者康复。针刺可促进膀胱运动,减轻尿功能障碍,但目前中药结合针灸治疗宫颈癌术后尿潴留的报道较少。

目的:探讨加味滋肾通管汤配合针刺治疗宫颈癌术后尿潴留的疗效观察及对不良反应发生率的影响。

方法:回顾性分析济南市中医院肿瘤科宫颈癌根治术后发生尿潴留的84例患者的临床资料。按入院顺序分为A组(n=42)和B组(n=42),A组采用常规治疗+滋肾通管汤+针刺治疗,B组仅常规治疗。观察两组患者的临床疗效,记录治疗后尿功能指标,分析两组患者的临床疗效及不良反应发生情况。

滋肾通管汤:山药、黄柏、知母、牛蒡子、茯苓20g,泽泻、伸筋草、牡丹皮、茯苓、山茱萸10g,黄芪50g,枳壳、熟地黄、桃仁、牛膝15g,附子、肉桂8g,三棱、姜黄12g,甘草6克。给予煎剂50 ml/次,每日3次,根据患者临床辩证予以加减。

患者术后第4天开始接受针灸治疗。取侧位,取阴陵泉、气海、关元、足三里、百会、双侧三阴交等穴位进行针刺。留针时间为30 min,每日1次,两组患者均连续治疗21天。

观察指标:智能尿流率检测仪检测治疗后的平均尿流率、最大尿流率和排尿时间。尿动力学分析仪检测逼尿肌压力膀胱顺应性水平值。残余尿量≤100ml,膀胱功能恢复良好。观察两组治疗后膀胱功能恢复良好的患者数量。两组患者治疗第7、14天的排尿情况以OABSS评分进行评价。量表包括白天排尿频次、夜间排尿频次、尿急、急迫性尿失禁,总分15分。得分越高,膀胱过动综合征越严重。

临床症状评估:(1)尿潴留消失,排尿顺畅,残尿量不超过50ml,即为治愈。如尿潴留基本消失,排尿稍有堵塞,残余尿量为51-100 ml,则为显效。如尿潴留减少,排尿持续时间较长,排尿时有疼痛和不适,残余尿量为51-100ml,则有效。如果患者不能自行排尿,则无效。记录两组不良反应发生率,包括皮疹、流涎、泌尿系统感染、恶心呕吐。

结果:与B组比较,A组患者的平均尿流率、最大尿流率、膀胱顺应性水平值、膀胱功能恢复良好患者数均明显升高,排尿时间、逼尿肌压力均明显降低。治疗7天时,两组患者膀胱过动综合征(OABSS)评分均值比较,差异无统计学意义。治疗14天时,A组平均OABSS明显低于B组。与B组比较,A组临床总有效率明显高于B组,不良反应总发生率明显低于B组。

结论:加味滋肾通管汤配合针刺治疗可显著提高宫颈癌术后尿潴留患者的治疗效果、膀胱顺应性及尿功能。因此,加味滋肾通管汤与针刺联合应用具有较高的临床价值。

文献来源:

Wang Shujuan., Wang Min., Zhang Hongbin.(2021). Effect Observation on Modified Zishen Tongguan Decoction Combined with Acupuncture in Treatment of Urinary Retention after Cervical Cancer Surgery and Its Influence on the Incidence of Adverse Reactions. Evid Based Complement Alternat Med, 2021(undefined), 7338276. doi:10.1155/2021/7338276

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1675382, encodeId=f1e316e538243, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Sat Mar 19 21:21:42 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222032, encodeId=b5d912220321e, content=<a href='/topic/show?id=2de44e466f4' target=_blank style='color:#2F92EE;'>#尿潴留#</a><a href='/topic/show?id=66ed9628563' target=_blank style='color:#2F92EE;'>#针灸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47466, encryptionId=2de44e466f4, topicName=尿潴留), TopicDto(id=96285, encryptionId=66ed9628563, topicName=针灸)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:27:09 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408327, encodeId=7d3b140832ed8, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Wed Dec 29 11:21:42 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-03-19 whmdzju
  2. [GetPortalCommentsPageByObjectIdResponse(id=1675382, encodeId=f1e316e538243, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Sat Mar 19 21:21:42 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222032, encodeId=b5d912220321e, content=<a href='/topic/show?id=2de44e466f4' target=_blank style='color:#2F92EE;'>#尿潴留#</a><a href='/topic/show?id=66ed9628563' target=_blank style='color:#2F92EE;'>#针灸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47466, encryptionId=2de44e466f4, topicName=尿潴留), TopicDto(id=96285, encryptionId=66ed9628563, topicName=针灸)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:27:09 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408327, encodeId=7d3b140832ed8, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Wed Dec 29 11:21:42 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1675382, encodeId=f1e316e538243, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Sat Mar 19 21:21:42 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222032, encodeId=b5d912220321e, content=<a href='/topic/show?id=2de44e466f4' target=_blank style='color:#2F92EE;'>#尿潴留#</a><a href='/topic/show?id=66ed9628563' target=_blank style='color:#2F92EE;'>#针灸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47466, encryptionId=2de44e466f4, topicName=尿潴留), TopicDto(id=96285, encryptionId=66ed9628563, topicName=针灸)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:27:09 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408327, encodeId=7d3b140832ed8, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46288, encryptionId=92194628826, topicName=宫颈)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11102737131, createdName=一闲, createdTime=Wed Dec 29 11:21:42 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 一闲

相关资讯

系统评价和荟萃分析:中药汤剂可治疗白塞病

白塞病(BD)是一种系统性血管炎的自身免疫性疾病,发病机制尚不清楚。尽管西药仍然是主要的干预措施,但有效性和安全性是重大挑战。补充和替代医学,包括草药,越来越受到关注。